Increased ERK activation and decreased MKP-1 expression in human myocardium with congestive heart failure

Keyphrases

• Congestive Heart Failure 100%
• ERK Activation 100%
• MKP-1 100%
• Human Myocardium 100%
• ERK1 50%
• Heart Failure Patients 50%
• Immunohistochemical Staining 37%
• Right Ventricle 37%
• Right Atrium 37%
• Left Atrium 37%
• Positive Staining 37%
• Cardiomyocytes 25%
• Left Ventricle 25%
• Myocardium 12%
• Growth Factors 12%
• Mitogen-activated Protein Kinase 12%
• Phosphatase 12%
• Tyrosine 12%
• ERK2 12%
• Threonine 12%
• Protein Phosphatase 12%
• Left Ventricular Strain 12%
• Serine-threonine Kinase 12%
• ERK Phosphorylation 12%
• Cardiac Transplantation 12%
• Cardiac Hypertrophy 12%
• Pathophysiological Roles 12%
• Dual Specificity 12%
• Cardiac Tissue 12%
• Patient Rights 12%

Medicine and Dentistry

• Myocardium 100%
• Congestive Heart Failure 100%
• Right Ventricle 37%
• Right Atrium 37%
• Left Atrium 37%
• Left Ventricle 37%
• Cardiac Muscle Cell 25%
• Phosphatase 12%
• Mitogen-Activated Protein Kinase 12%
• Growth Factor 12%
• Threonine 12%
• Protein Kinases 12%
• Phosphoprotein Phosphatase 12%
• Heart Transplantation 12%
• Protein Serine Threonine Kinase 12%
• Mitogen Activated Protein Kinase 3 12%
• Mitogen Activated Protein Kinase 1 12%
• Ventricular Hypertrophy 12%
• Patient Rights 12%

Biochemistry, Genetics and Molecular Biology

• Normal Human 100%
• Cardiac Muscle Cell 50%
• Threonine 50%
• Protein Kinases 25%
• Growth Factor 25%
• Mitogen-Activated Protein Kinase 25%
• Tyrosine 25%
• Phosphoprotein Phosphatase 25%
• Phosphatase 25%
• Serine 25%